Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Kiniksa Pharmaceuticals, Ltd. (KNSA)  
$19.53 0.66 (3.27%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 35,410,000
Market Cap: 691.56(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $13.21 - $21.74
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Kiniksa Pharmaceuticals is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with unmet medical need. Co.'s portfolio of assets include: ARCALYST® (rilonacept) is for the treatment of Cryopyrin-Associated Periodic Syndrome; mavrilimumab is targeting granulocyte-macrophage colony stimulating factor receptor alpha; vixarelimab is evaluating vixarelimab for the potential treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404 is a humanized monoclonal antibody that is designed to inhibit the CD40-CD154 interaction.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 128,310 194,896 224,296 274,612
Total Sell Value $2,726,499 $3,969,036 $4,531,208 $5,316,305
Total People Sold 4 5 5 6
Total Sell Transactions 8 12 14 16
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 241
  Page 7 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Baker Brothers Life Sciences Lp Director   –       •      –    2022-06-29 4 A $0.00 $0 I/I 20,000 2,710,597     -
   Ragosa Mark CHIEF FINANCIAL OFFICER   •       –      –    2022-04-26 4 D $9.99 $2,817 D/D (282) 6,357     -
   Ragosa Mark CHIEF FINANCIAL OFFICER   •       –      –    2022-04-26 4 OE $0.00 $0 D/D 991 6,639     -
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2022-03-21 4 D $10.98 $59,797 D/D (5,446) 17,756     -
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2022-03-21 4 OE $0.00 $0 D/D 18,555 23,202     -
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2022-03-21 4 D $10.98 $12,298 D/D (1,120) 6,041     -
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2022-03-21 4 OE $0.00 $0 D/D 3,231 7,161     -
   Ragosa Mark CHIEF FINANCIAL OFFICER   •       –      –    2022-03-21 4 D $10.98 $11,496 D/D (1,047) 5,648     -
   Ragosa Mark CHIEF FINANCIAL OFFICER   •       –      –    2022-03-21 4 OE $0.00 $0 D/D 3,019 6,695     -
   Moat Ross CHIEF COMMERCIAL OFFICER   •       –      –    2022-03-21 4 D $10.98 $13,615 D/D (1,240) 7,372     -
   Moat Ross CHIEF COMMERCIAL OFFICER   •       –      –    2022-03-21 4 OE $0.00 $0 D/D 2,270 8,612     -
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2022-03-21 4 D $10.98 $16,042 D/D (1,461) 112,213     -
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2022-03-21 4 OE $0.00 $0 D/D 4,611 113,674     -
   Paolini John F. CHIEF MEDICAL OFFICER   •       –      –    2022-03-21 4 D $10.98 $18,512 D/D (1,686) 35,117     -
   Paolini John F. CHIEF MEDICAL OFFICER   •       –      –    2022-03-21 4 OE $0.00 $0 D/D 5,676 36,803     -
   Moat Ross Chief Commercial Officer   •       –      –    2022-03-16 4 D $10.13 $5,511 D/D (544) 6,342     -
   Moat Ross Chief Commercial Officer   •       –      –    2022-03-16 4 OE $0.00 $0 D/D 995 6,886     -
   Patel Sanj K Chairman & CEO   •       •      –    2022-03-16 4 D $10.13 $19,470 D/D (1,922) 4,647     -
   Patel Sanj K Chairman & CEO   •       •      –    2022-03-16 4 OE $0.00 $0 D/D 6,569 6,569     -
   Paolini John F. Chief Medical Officer   •       –      –    2022-03-16 4 D $10.13 $6,058 D/D (598) 31,127     -
   Paolini John F. Chief Medical Officer   •       –      –    2022-03-16 4 OE $0.00 $0 D/D 1,725 31,725     -
   Tessari Eben Chief Operating Officer   •       –      –    2022-03-16 4 D $10.13 $6,899 D/D (681) 109,063     -
   Tessari Eben Chief Operating Officer   •       –      –    2022-03-16 4 OE $0.00 $0 D/D 1,964 109,744     -
   Ragosa Mark Chief Financial Officer   •       –      –    2022-03-16 4 D $10.13 $3,069 D/D (303) 3,676     -
   Ragosa Mark Chief Financial Officer   •       –      –    2022-03-16 4 OE $0.00 $0 D/D 872 3,979     -

  241 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed